Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can hospitals boost vaccine access for the most vulnerable?

NCT ID NCT07391046

First seen Feb 05, 2026 · Last updated Jun 23, 2026 · Updated 18 times

Summary

This study will test a new way to offer vaccines to vulnerable patients—those with chronic diseases or weakened immune systems—during hospital visits. Researchers will see if offering, prescribing, and giving vaccines in the hospital increases how many people get vaccinated. The goal is to make it easier for high-risk patients to stay protected against preventable diseases.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this model could make it easier for vulnerable patients to get recommended vaccines during hospital visits, potentially preventing serious infections.

What could go wrong

This is an observational study, not a test of a new treatment. It only measures how well the vaccination program works, not whether vaccines prevent disease. Results may not apply to other hospitals.

Conditions

The condition(s) this trial relates to.

autoimmune disease cancer Chronic Disease chronic kidney disease chronic renal failure syndrome familial isolated congenital asplenia Frailty HIV infectious disease immunodeficiency disease inflammatory bowel disease neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.